- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Gloucester Pharmaceuticals Inc.
Headquarters: Cambridge, MA, United States
Website: N/A
Year Founded: 2003
Status: Acquired
BioCentury | May 25, 2018
Financial News
Consonance, Jay Mohr partner to invest in deprioritized therapeutics
BioCentury | May 22, 2018
Financial News
Consonance, Jay Mohr partner to invest in deprioritized therapeutics
BioCentury | Aug 5, 2013
Strategy
Future-proofing MM
Celgene's Acetylon option enables epigenetic combinations in multiple myeloma
BioCentury | Jan 7, 2013
Finance
Novo's public moves
Novo Ventures boosting investments by 50% to add public life science plays
BioCentury | Jan 30, 2012
Strategy
Committing to covalency
Avila gives Celgene a new discovery platform as well as complement to Revlimid
BioCentury | Oct 10, 2011
Finance
Venture's stress
Why Prospect will return $150M to LPs rather than invest new biotech VC fund
Items per page:
1 - 10 of 83